Amakem's Grant

Amakem raised a round of funding on January 03, 2013. Investors include IWT.

Amakem is a kinase platform company focusing on ophthalmology and is developing new treatments for serious eye conditions. The Company's lead candidate, AMA0076, targets glaucoma, a condition which da…

Articles about Amakem's Grant: